Home › Schizophrenia › Maryland
Schizophrenia clinical trials in Maryland
17 studies for Schizophrenia are looking for participants at sites in Maryland.
Cities in Maryland
Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia
- Local Institution - 0192, Gaithersburg
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Sep 28, 2026 · NCT07686263NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
- Neurocrine Clinical Site, Gaithersburg
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Sep 25, 2026 · NCT07114874A Study of Brenipatide in Adult Participants With Schizophrenia
- CBH Health, Gaithersburg
RecruitingPhase 2
Ages 18 to 55 · All sexes · Updated Sep 22, 2026 · NCT07410507A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia
- CBH Health LLC., dba CenExel Gaithersburg MD, Gaithersburg
RecruitingPhase 1
Ages 18 to 55 · All sexes · Updated Sep 17, 2026 · NCT07734493A Study to Assess Adverse Events, Change in Disease Activity, and How Oral Emraclidine Moves Through the Body in Adult Participants With Schizophrenia
- Cbh Health - Gaithersburg /ID# 272932, Gaithersburg
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Sep 15, 2026 · NCT0714591852-week Open Label Safety-Tolerability Study
- CenExel Gaithersburg, Gaithersburg
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Sep 9, 2026 · NCT07369154A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
- Clinical Site, Gaithersburg
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Sep 1, 2026 · NCT07459647Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)
- The Johns Hopkins Hospital, Baltimore
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 19, 2026 · NCT07101094A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia
- Cenexel CBH, Gaithersburg
RecruitingPhase 2
Ages 18 to 55 · All sexes · Updated Jun 23, 2026 · NCT07191483Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial
- University of Maryland School of Medicine, Baltimore
RecruitingPhase 4
Ages 18 to 65 · All sexes · Updated May 4, 2026 · NCT05208190Synbiotic Compound to Reduce Symptoms of Schizophrenia
- Sheppard Pratt Health System, Batlimore
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Apr 7, 2026 · NCT04226898NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
- Neurocrine Clinical Site, Gaithersburg
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Mar 6, 2026 · NCT06963034White Matter Plasticity in Schizophrenia
- Maryland Psychiatric Research Center, Catonsville
- University of Maryland Baltimore - Maryland Psychiatric Research Center, Catonsville
Recruiting
Ages 15 to 45 · All sexes · Updated Feb 20, 2026 · NCT06641297TMS for Inhibition Enhancement in Schizophrenia
- Maryland Psychiatric Research Center, Catonsville
Recruiting
Ages 18 to 45 · All sexes · Updated Feb 13, 2026 · NCT06155682CBT-CP for Veterans With SMI
- Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD, Baltimore
Recruiting
Ages 18 and older · All sexes · Updated Feb 9, 2026 · NCT06758414Study of ALTO-101 in Patients With Schizophrenia
- Site 5062, Gaithersburg
RecruitingPhase 2
Ages 21 to 55 · All sexes · Updated Dec 26, 2025 · NCT06502964Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
- Reviva site, Gaithersburg
RecruitingPhase 3Healthy volunteers welcome
Ages 18 to 65 · All sexes · Updated Dec 19, 2024 · NCT05184335From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.